Abstract
Monoclonal antibodies to the thyrotropin (TSH) receptor have been obtained from fusions of mouse myeloma cells with spleen cells immunized with solubilized thyroid membrane preparations. Two monoclonal antibodies which inhibit 125l-TSH binding and are reactive with the glycoprotein component of the bovineTSH receptor (11E8 and 13D11), are shown to inhibit basal and TSH stimulated adenylate cyclase activity in bovine thyroid membranes and human thyroid cells. Both antibodies also inhibit 125l-TSH binding in vitro, whether binding is measured at pH 6.0 in low salts and at 0–4 C or at pH 7.4 in 50 mM NaCl and at 37 C. The glycoprotein component is thus a portion of the physiologic TSH receptor in vivo and 125l-TSH binding studies apparently measure the high affinity glycoprotein component under nonphysiologic conditions and conditions more representative of the physiologic milieu. A third monoclonal antibody whose interaction with thyroid membranes is prevented by TSH is shown to stimulate adenylate cyclase activity in bovine thyroid membranes and human thyroid cells. This stimulating antibody only weakly inhibits 125l-TSH binding to thyroid membranes or to the glycoprotein component of the TSH receptor. The 22A6 antibody does, however, immunoprecipitate mixed brain gangliosides, in distinct contrast to the monoclonal antibodies to the glycoprotein receptor component, i.e., 11E8 and 13D11. The results support the speculation that autoimmune antibodies which inhibit TSH binding to thyroid membranes are not necessarily identical to antibodies which stimulate function; that antibodies directed at the high affinity initial site of TSH interaction with a cell can behave as blocking rather than stimulating antibodies and that a possible relationship exists between stimulating antibodies and the low affinity TSH binding sites (gangliosides) on thyroid membranes.
Similar content being viewed by others
Abbreviations
- GM1 :
-
galactosyl-N-acetylgalactosaminyl-(N-acetylneura-minyl) — galactosylglucosylceramide
- GD1a :
-
N-acetylneuraminylgalactosyl-N-acetylgalactosaminyl — (N-acetylneuraminyl)-galactosylglucosylceramide
- GDI b :
-
galactosyl-N-acetylgalactosaminyl — (N-acetyl-neuraminyl-N-acetylneuraminyl) —galactosylglucosylceramide
- GT1 :
-
N-acetylneuraminylgalactosyl-N-acetylgalac-tosaminyl (N-acetylneuraminyl-N-acetylneuraminyl) — galactosylglucosylceramide
- KRB:
-
Kreks Ringers Buffer
- BSA:
-
bovine serum albumin
- HBSS:
-
Hanks Balanced Salts Solution
- IMX:
-
3-isobutyl-l-methyl-xanthine.
References
Yavin E., Yavin Z., Schneider M.D., Kohn L.D. Monoclonal antibodies to the thyrotropin receptor; implications for receptor structure and the action of autoantibodies in Graves’ disease. Proc. Natl. Acad. Sci. USA 78: 3180, 1981.
Yavin E., Yavin Z., Schneider M.D., Kohn L.D. Monoclonal antibodies to the thyrotropin receptor: interaction with thyroid membranes on solid surfaces and on thyroid cells. In: Fellows R.E., Eisenbarth G. (Eds.), monoclonal Antibodies in endocrine research. Raven Press, New York, 1981, p. 53.
Yavin E., Yavin Z., Schneider M.D., Kohn L.D. Monoclonal antibodies as probes for ligand-receptor interactions: studies of the thyrotropin receptor. In: Owen D. (Ed.), Cold Spring Harbor Symposium on Monoclonal Antibodies. Cold Spring Harbor Laboratories, New York, 1981. (in press).
Winand R.J., Kohn L.D. Thyrotropin effects on thyroid cells in culture; effects of trypsin on the thyrotropin receptor and on thyrotropin-mediated cyclic 3″:5′ — AMP changes. J. Biol. Chem. 250: 6534, 1975.
Tate R.L., Schwartz H.I., Holmes J.M., Kohn L.D., Winand R.J. Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by trypsin digestion. J. Biol. Chem. 250: 6509, 1975.
Tate R.L., Holmes J.M., Kohn L.D., Winand R.J. Characteristics of solubilized thyrotropin receptor from bovine thyroid plasma membranes. J. Biol. Chem. 250: 6527, 1975.
Tate R.L., Winand R.J., Kohn L.D. Solubilization and partial purification of the thyrotropin receptor. In: Robbins R., Braverman L. (Eds.), Thyroid research. Excerpta Medica, Amsterdam, 1976, p. 57.
Meldolesi M.F., Fishman P.H., Aloj S.M., Ledley F.D., Lee G., Bradley R.M., Brady R.O., Kohn L.D. Separation of the glycoprotein and ganglioside components of thyrotropin receptor activity in plasma membranes. Biochem. Biophys. Res. Commun. 75: 581, 1977.
De Wolf M.J.S., Yavin E., Yavin Z., Consiglio E., Vitti P., Shifrin S., Epstein M., Gill D.L., Grollman E.F., Lee G., Kohn L.D. Studies on the mechanism of action of thyrotropin. In: Albertini E. (Ed.), Radioimmunoassay of hormones, proteins and enzymes. International Congress Series No. 528, Elsevier North-Holland, Amsterdam, 1980, p. 3.
Winand R.J., Kohn L.D. Relationships of thyrotropin to exophthalmic-producing substance: Purification of homogeneous glycoproteins containing both activities from [3H]-labeled pituitary extracts. J. Biol. Chem. 245: 967, 1970.
Amir S.M., Carraway T.F. Jr., Kohn L.D., Winand R.J. The binding of thyrotropin to isolated bovine thyroid plasma membranes. J. Biol. Chem. 248: 4092, 1973.
Veh R.W., Corfield A.P., Sandler N., Schauer R. Neuraminic acid-specific modification and tritium labeling of gangliosides. Biochim. Biophys. Acta 486: 145, 1977.
Aloj S.M., Lee G., Grollman E.F., Beguniot F., Consiglio E., Kohn L.D. Role of phospholipids in the structure and function of the thyrotropin receptor. J. Biol. Chem. 254: 9040, 1979.
Aloj S.M., Kohn L.D., Lee G., Meldolesi M.F. The binding of thyrotropin to liposomes containing gangliosides. Biochem. Biophys. Res. Commun. 74: 1053, 1977.
Salomon Y. Adenylate cyclase assays. In: Greengard P., Robison, G.A. (Eds.), Advances in cyclic nucleotide research. Raven Press, New York, 1979, Vol. 10, p. 35.
Vitti P., De Wolf M.J.S., Acquaviva A.M., Epstein M., Kohn L.D. Thyrotropin stimulation of the ADP ribosyltransferase activity of bovine thyroid membranes. Proc. Natl. Acad. Sci. USA 78: 1981. (in press).
Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193: 265, 1951.
Trisler G.S., Schneider M.S., Niremberg M. Topographic gradient of molecules in retina can be used to identify neural position. Proc. Natl. Acad. Sci. USA 78: 2145, 1981.
Toccafondi R.S., Aterini S., Medici M.A., Rotella E.M., Tanini A., Zonefrati R. Thyroid stimulating antibody (TSAb) detected in sera of Graves’ patients using human thyroid cell cultures. Clin. Exp. Immunol. 40: 532, 1980.
Brown B.L., Albano J.D.M., Ekins R.P., Sgherzi A.M., Tampion W. A simple and sensitive saturation assay method for the measurement of adenosine 3′. 5-cyclic monophosphate. J. Biochem. 121: 561, 1971.
Kissane J.M., Robins E. The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. J. Biol. Chem. 233: 184, 1958.
Ambesi-lmpiombato F.S., Parks L.A.M., Coon H.G. Culture of hormone dependent epethelial cells from rat thyroids. Proc. Natl. Acad. Sci. USA 77: 3455, 1980.
Mandato E., Catopano R., Ambesi-lmpiombato F.S., Macchia V. Hormone stimulated adenylate cyclase activity of cultured rat thyroid cells. Biochim. Biophys. Acta 676: 91, 1981.
Beckner S.K., Brady R.O., Fishman P.H. Reevaluation of the role of gangliosides in the binding and action of thyrotropin. Proc. Natl. Acad. Sci. USA 78: 4848, 1981.
Bagchi N., Fawcell D.M. Role of sodium ion in active transport of iodide by cultured thyroid cells. Biochim. Biophys. Acta 318: 235, 1973.
Pekonen F., Weintraub B.D. Salt induced exposure of high affinity thyrotropin receptors on human and porcine thyroid membranes. J. Biol. Chem. 255: 8121, 1980.
Ross E.M., Gilman A.G. Biochemical properties of hormone-sensitive adenylate cyclase. Annu. Rev. Biochem. 49: 533, 1980.
De Wolf M.J.S., Vitti P., Ambesi-Impiombato F.S., Kohn L.D. Thyroid membrane ADP ribosyltransferase activity: Stimulation by thyrotropin and activity in functioning and nonfunctioning rat thyroid cells in culture. J. Biol. Chem. 256: 12287, 1981.
Filetti S., Takai N.A., Rapoport B. Prevention by nicotinamide of desensitization to thyrotropin stimulation in cultured human thyroid. J. Biol. Chem. 256: 1072, 1981.
Kohn L.D. Relationships in the structure and function of receptors for glycoprotein hormones, bacterial toxins and interferon. In: Cuatrecasas P., Greaves M.F. (Eds.), Receptors and recognition, Series A. Chapman and Hall, London, 1978, Vol. 5, p. 133.
Kohn L.D., Consiglio E., Aloj S.M., Beguinot F., De Wolf M.J.S., Yavin E., Yavin Z., Meldolesi M.F., Shifrin S., Gill D.L., Vitti P., Lee G., Valente W.A., Grollman E.F. The structure of the thyrotropin (TSH) receptor: potential role of gangliosides and relationship to receptors for interferon and bacterial toxins. In: Schweiger H.G. (Ed.), International cell biology, 1980–81. Springer-Verlag, Berlin, 1981, p. 696.
Kohn L.D., Consiglio E., De Wolf M.J.S., Grollman E.F., Ledley F.D., Lee G., Morris N.P. Thyrotropin receptors and gangliosides. In: Svennerholm L., Mandel P., Dreyfus H., Urban P.F. (Eds.), Structure and function of gangliosides, Plenum Press, N.Y. Adv. Exp. Med. Biol. 125: 487, 1980.
Kohn L.D., Meldolesi M.F., Aloj S.M., Vitti P., Valente W.A., Laccetti P., Cohen J.L., Dianzani U., Grollman E.F. A molecular model of the thyrotropin receptor: experimental and human thyroid tumors with relevant defects. In: Andreoli M., Monaco F., Robbins J. (Eds.), International Symposium on Thyroid Neoplasia. Raven Press, New York, 1982. (in press).
Aloj S.M., Lee G., Consiglio E., Formisano S., Minton A.P., Kohn L.D. Dansylated thyrotropin as a probe of hormone-receptor interactions. J. Biol. Chem. 254: 9030, 1979.
Carayon P., Macchia E., Fenzi G.F., Pinchera A., Lissitzky S. Agonism and antagonism of immunoglobulins from Graves’ disease patients on TSH stimulated thyroid adenylate cyclase. In: Pinchera A., Doniach D., Fenzi G.F., Baschieri L. (Eds.), Autoimmune aspects of endocrine disorders. Academic Press, New York, 1981, p. 167.
Minton A.P. The bivalent ligand hypotheses: A quantitative model for hormone action. Mol. Pharmacol. 19: 1, 1981.
Smith B.R., Hall R. Thyroid-stimulating immunoglobulins in Graves’ disease. Lancet 24: 427, 1974.
Mukhtar E.D., Smith B.R., Pyle G.A., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet 1: 713, 1975.
Hall R., Smith B.R., Mukhtar E.D. Thyroid stimulators in health and disease. Clin. Endocrinol. (Oxf.) 4: 213, 1975.
Mehdi S.Q., Nussey S.S., Gibbons C.P., El Kabir D.J. Binding of thyroid stimulators to human thyroid membranes. Biochem. Soc. Trans. 1: 1005, 1973.
Mehdi S.Q., Nussey S.S. A radio-ligand receptor assay for the long-acting thyroid stimulator. Biochem. J. 145: 105, 1975.
Manley S.W., Bourke J.R., Hawker R.W. The thyrotropin receptor in guinea-pig thyroid homog-enate: interaction with long-acting thyroid stimulator. J. Endocrinol. 61: 437, 1974.
McKenzie J.M., Zakarija M. A reconsideration of thyroid stimulating immunoglobulin as the cause of hyperthyroidism in Graves’ disease. J. Clin. Endocrinol. Metab. 42: 778, 1976.
Zakarija M., McKenzie J.M. The thyroid stimulating antibody of Graves’ disease: its assay, some physiochemical characteristics and clinical significance. In: Pinchera A., Doniach D., Fenzi G.F., Baschieri L. (Eds.), Autoimmune aspects of endocrine disorders. Academic Press, New York, 1980, p. 83.
Sugenoya A., Kidd A., Row V.V., Volpe R. Correlation between thyrotropin-displacing activity and human thyroid stimulating activity by immunoglobulins from patients with Graves’ disease arid other thyroid disorders. J. Clin. Endocrinol. Metab. 48: 398, 1979.
Pinchera A., Fenzi G., Bartalena L., Chiovato L., Marcocci C., Toccafondi R., Rotella C., Aterini S., Zonefrati R. Thyroid cell-surface and thyroid-stimulating antibodies in patients with thyroid autoimmune disorders. In: Stockight J.R., Nagataki S. (Eds.), Thyroid research, VIII. Australian Academy of Science, Canberra, 1980, p. 707.
Ozawa Y., Maciel R.M.B., Chopra I.J., Solomon D.H., Beall G.N. Relationships among immunoglobulin markers in Graves’ disease. J. Clin. Endocrinol. Metab. 48: 381, 1979.
Macchia E., Fenzi G.F., Monzani F., Lippi F., Vitti P., Grasso L., Bartalena L., Baschieri L., Pinchera A. Comparison between thyroid-stimulating and TSH-binding inhibiting immunoglobulins of Graves’ disease. Clin. Endocrinol. (Oxf.) 15: 175, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valente, W.A., Yavin, Z., Yavin, E. et al. Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies. J Endocrinol Invest 5, 293–302 (1982). https://doi.org/10.1007/BF03350517
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350517